Effect of comorbidities on outcomes and ivabradine effects in patients with chronic systolic heart failure in the SHIFT trial

被引：0
|
作者：
Bohm, Servier M. [1 ]
Borer, J. S. [2 ]
Ford, I. [3 ]
Lainscak, M. [4 ]
Komajda, M. [5 ]
Robertson, M. [3 ]
Tavazzi, L. [6 ]
Swedberg, K. [7 ]
机构：
[1] Univ Saarlandes Kliniken, Innere Med Klin 3, Homburg, Germany
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[4] Gen Hosp Celje, Dept Cardiol, Celje, Slovenia
[5] Univ Paris 06, La Pitie Salpetriere Hosp, Dept Cardiol, Paris, France
[6] Ettore Sansavini Hlth Sci Fdn, Maria Cecilia Hosp GVM Care & Res, Cotignola, Italy
[7] Univ Gothenbur, Sahlgrenska Acad, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1283
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [41] Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients
    Bonadei, Ivano
    Sciatti, Edoardo
    Vizzardi, Enrico
    Fabbricatore, Davide
    Pagnoni, Mattia
    Rossi, Laura
    Carubelli, Valentina
    Lombardi, Carlo M.
    Metra, Marco
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (03)
  • [42] Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart Failure
    Sargento, Luis
    Satendra, Milan
    Longo, Susana
    Lousada, Nuno
    dos Reis, Roberto Palma
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (03) : 229 - 235
  • [43] Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart Failure
    Luis Sargento
    Milan Satendra
    Susana Longo
    Nuno Lousada
    Roberto Palma dos Reis
    American Journal of Cardiovascular Drugs, 2014, 14 : 229 - 235
  • [44] Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure
    Tondi, Lara
    Fragasso, Gabriele
    Spoladore, Roberto
    Pinto, Giuseppe
    Gemma, Marco
    Slavich, Massimo
    Godino, Cosmo
    Salerno, Anna
    Montanaro, Claudia
    Margonato, Alberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (07) : 351 - 356
  • [45] Ivabradine effects on heart rate and quality of life among chronic heart failure patients
    Farooq, Fawad
    Imran, Nida
    Abbas, Mahwish
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (01) : 86 - 89
  • [46] Effect of chronic heart rate reduction by ivabradine on left ventricular systolic and diastolic dysfunctions in rats with chronic heart failure.
    Mellin, V
    Mulder, P.
    Richard, V
    Henry, J. P.
    Mahlberg-Gaudin, F.
    Lerelbours, G.
    Thuillez, C.
    HYPERTENSION, 2006, 48 (04) : 765 - 765
  • [47] BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY
    Borer, Jeffrey S.
    Swedberg, Karl
    Komajda, Michel
    Ford, Ian
    Tavazzi, Luigi
    Boehm, Michael
    Dominjon, Fabienne
    Maya, Juan
    Wu, Yuna
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A872 - A872
  • [48] Ivabradine in acute decompensated systolic heart failure
    Sargento, Luis
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 235 : 197 - 197
  • [49] Ivabradine in acute decompensated systolic heart failure
    Jose Hidalgo, Francisco
    Anguita, Manuel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 235 : 198 - 198
  • [50] How many patients with systolic heart failure patients have an indication for ivabradine?
    Balestrieri, G.
    Russell, K.
    Mcinnes, N.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S184 - S184
12345